Glucagon Like Peptide 1 Analogs Market Expansion Attributed to Advancements in Diabetes Care and Management

The Glucagon Like Peptide 1 (GLP-1) analogs market has emerged as a viable pharmacological option for the management of type 2 diabetes. GLP-1 analogs help mimic the actions of naturally occurring incretin hormones GLP-1 that stimulate insulin secretion and lower glucagon secretion in a glucose-dependent manner. The growing prevalence of obesity

read more


Growing India Pharmaceutical Packaging Industry

Regulatory Environment and Drug Approval Process The pharmaceutical industry in India operates in a regulated environment with oversight provided by the Central Drugs Standard Control Organization (CDSCO). CDSCO is responsible for approving new drugs and clinical trials, laying down standards for drugs, and banning unsafe drugs. Any new drug must

read more